Vieira Roberto Wandenkolk: insider trades.
Vieira Roberto Wandenkolk reported 12 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 8 sales ($6.5M), across 1 company.
- Transactions
- 12
- Purchases (P)
- 0
- Sales (S)
- 8
- Companies
- 1
- Name as filed
- Vieira Roberto Wandenkolk
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Corcept Therapeutics Inc (CORT) | Officer · President, Oncology | 12 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | Corcept Therapeutics Inc | S | 296 | $100.82 | 3,946 | Form 4 |
| 2026-09-02 | Corcept Therapeutics Inc | S | 1,225 | $115.44 | 4,242 | Form 4 |
| 2026-09-02 | Corcept Therapeutics Inc | S | 5,621 | $114.58 | 5,467 | Form 4 |
| 2026-09-02 | Corcept Therapeutics Inc | S | 1,606 | $113.72 | 11,088 | Form 4 |
| 2026-09-02 | Corcept Therapeutics Inc | S | 1,537 | $111.37 | 13,668 | Form 4 |
| 2026-09-02 | Corcept Therapeutics Inc | S | 23,770 | $110.7 | 15,205 | Form 4 |
| 2026-09-02 | Corcept Therapeutics Inc | S | 23,600 | $109.35 | 38,975 | Form 4 |
| 2026-09-02 | Corcept Therapeutics Inc | M | 58,333 | $21.63 | 62,575 | Form 4 |
| 2026-09-02 | Corcept Therapeutics Inc | F | 102 | $113.38 | 4,242 | Form 4 |
| 2026-09-02 | Corcept Therapeutics Inc | S | 974 | $112.4 | 12,694 | Form 4 |
| 2026-09-01 | Corcept Therapeutics Inc | A | 138 | $0 | 4,344 | Form 4 |
| 2026-09-01 | Corcept Therapeutics Inc | A | 138 | $113.38 | 4,206 | Form 4 |
Questions
What stock did Vieira Roberto Wandenkolk buy or sell?
Vieira Roberto Wandenkolk reported 12 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 8 sales ($6.5M), across 1 company.
Is Vieira Roberto Wandenkolk the same person as other filers with this name?
This page covers SEC CIK 2150104 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/vieira-roberto-wandenkolk-2150104.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.